Search
Citius Oncology Inc
CTORAdd to Watchlist
0.675USD
-0.029-4.16%
Market hours （ET）Quotes delayed by 15 min
56.37MMarket Cap
LossP/E TTM
Citius Oncology Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Citius Oncology Inc is 7.36, ranking 234 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.47, which is -55.55% below the recent high of -0.65 and -118.27% above the recent low of -3.20.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.